STUB1 and cancer: As shown in Table II, pathological T stage (P=0.002), stage (P=0.002), differentiation (P=0.047), lymphatic invasion (P=0.027) and CHIP expression (P=0.029) were statistically significant risk factors affecting the cancer-specific survival of patients with GBC.